OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Publication of Shareholder Circular
Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and COVID-19 testing, confirms that the Circular to Shareholders in respect of the Fundraising, announced on 19 June 2020, is now available on the Company's website here:
http://www.omegadiagnostics.com/Investor-Relations/Corporate-Information
Contacts:
|
Omega Diagnostics Group PLC |
Tel: 01259 763 030 |
|
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive |
|
|
Kieron Harbinson, Group Finance Director |
|
|
finnCap Ltd |
Tel: 020 7220 0500 |
|
Geoff Nash/Hannah Boros (Corporate Finance) |
|
|
Camille Gochez (ECM) |
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or [email protected] |
|
Paul McManus |
Mob: 07980 541 893 |
|
Lianne Cawthorne |
Mob: 07584 391 303 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.